These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35717320)

  • 1. Maximal surgical effort increases the risk of postoperative complications in the treatment of advanced ovarian cancer.
    Kuusela K; Norppa N; Auranen A; Saarelainen S
    Eur J Surg Oncol; 2022 Dec; 48(12):2525-2530. PubMed ID: 35717320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
    Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
    Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative complications in women with ovarian cancer stratified by cytoreductive surgery outcome.
    Polan RM; Slota JM; Barber EL
    J Surg Oncol; 2023 Oct; 128(5):891-901. PubMed ID: 37382209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-radical surgery versus standard-radical surgery for the primary cytoreduction of advanced epithelial ovarian cancer; long-term tertiary center experiences.
    Aksan A; Boran N; Sinem Duru Coteli A; Ustun Y
    Eur J Obstet Gynecol Reprod Biol; 2024 Nov; 302():125-133. PubMed ID: 39265198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-radical surgery for advanced ovarian cancer: a retrospective cohort study in a tertiary referral cancer center in the UK.
    Palaiologos K; Nikoloudaki Z; Adedipe T; Flynn M; Booth S; Lykoudis P; Giannopoulos T
    Minerva Obstet Gynecol; 2024 Aug; 76(4):319-326. PubMed ID: 37058318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancer.
    Angeles MA; Hernández A; Pérez-Benavente A; Cabarrou B; Spagnolo E; Rychlik A; Daboussi A; Migliorelli F; Bétrian S; Ferron G; Gil-Moreno A; Guyon F; Martinez A
    Gynecol Oncol; 2022 Jul; 166(1):8-17. PubMed ID: 35568582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative Complications of Upfront Ovarian Cancer Surgery and Their Effects on Chemotherapy Delay.
    Heikkinen J; Kärkkäinen H; Eloranta ML; Anttila M
    Curr Oncol; 2024 Sep; 31(9):5630-5642. PubMed ID: 39330045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis.
    Ghirardi V; Moruzzi MC; Bizzarri N; Vargiu V; D'Indinosante M; Garganese G; Pasciuto T; Loverro M; Scambia G; Fagotti A
    Gynecol Oncol; 2020 Apr; 157(1):209-213. PubMed ID: 31952843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of surgical volume on short-term outcomes of cytoreductive surgery for advanced-stage ovarian cancer: A population-based study from the Dutch Gynecological Oncology Audit.
    Algera MD; van Driel WJ; Slangen BFM; Wouters MWJM; Kruitwagen RFPM;
    Gynecol Oncol; 2024 Jul; 186():144-153. PubMed ID: 38688188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival after implementation of ultra-radical surgery in advanced epithelial ovarian cancer: Results from a tertiary referral center.
    Norppa N; Staff S; Helminen M; Auranen A; Saarelainen S
    Gynecol Oncol; 2022 Jun; 165(3):478-485. PubMed ID: 35397919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive validity of American College of Surgeons: National Surgical Quality Improvement Project risk calculator in patients with ovarian cancer undergoing interval debulking surgery.
    Manning-Geist B; Cathcart AM; Sullivan MW; Pelletier A; Cham S; Muto MG; Del Carmen M; Growdon WB; Sisodia RC; Berkowitz R; Worley M
    Int J Gynecol Cancer; 2021 Oct; 31(10):1356-1362. PubMed ID: 34518239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validation and comparison of the Comprehensive Complication Index and Clavien-Dindo classification in predicting post-operative outcomes after cytoreductive surgery in advanced ovarian cancer.
    Kengsakul M; Nieuwenhuyzen-de Boer GM; Udomkarnjananun S; Kerr SJ; van Doorn HC; van Beekhuizen HJ
    Int J Gynecol Cancer; 2023 Feb; 33(2):263-270. PubMed ID: 36600504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis.
    Xu Y; Jia Y; Zhang Q; Du Y; He Y; Zheng A
    Gynecol Oncol; 2021 Feb; 160(2):610-618. PubMed ID: 33221022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery.
    Kranawetter M; Ataseven B; Grimm C; Schneider S; Riss S; Alesina P; Prader S; Walz MK; Harpain F; Stift A; Heitz F; Reinthaller A; Polterauer S; Harter P; du Bois A
    Gynecol Oncol; 2019 Sep; 154(3):577-582. PubMed ID: 31235241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of residual disease at interval debulking surgery on platinum resistance and patterns of recurrence for advanced-stage ovarian cancer.
    Greer A; Gockley A; Manning-Geist B; Melamed A; Sisodia RC; Berkowitz R; Horowitz N; Del Carmen M; Growdon WB; Worley M
    Int J Gynecol Cancer; 2021 Oct; 31(10):1341-1347. PubMed ID: 34429355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic interval debulking surgery for advanced epithelial ovarian cancer: current challenge or future direction? A systematic review.
    Psomiadou V; Prodromidou A; Fotiou A; Lekka S; Iavazzo C
    J Robot Surg; 2021 Apr; 15(2):155-163. PubMed ID: 33037532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technical essentials and safety analysis of "rolling carpet" cytoreduction surgery in stage Ⅲc epithelial ovarian cancer].
    Liu H; Shi Y; Zhang GN; Yu J; Xu SQ; Wang DF; Fan Y; Song SQ; Zhou FZ
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):521-528. PubMed ID: 32854476
    [No Abstract]   [Full Text] [Related]  

  • 19. Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events.
    Straubhar AM; Wolf JL; Zhou MQC; Iasonos A; Cham S; Wright JD; Long Roche K; Chi DS; Zivanovic O
    Gynecol Oncol; 2021 Feb; 160(2):438-444. PubMed ID: 33272645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance validation of the Mayo triage algorithm applied to individualize surgical management of advanced epithelial ovarian cancer.
    Jiang C; Li Z
    Gynecol Oncol; 2021 Aug; 162(2):339-344. PubMed ID: 34147283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.